scholarly article | Q13442814 |
meta-analysis | Q815382 |
review article | Q7318358 |
P6179 | Dimensions Publication ID | 1013232041 |
P356 | DOI | 10.1038/EJCN.2011.64 |
P698 | PubMed publication ID | 21559039 |
P5875 | ResearchGate publication ID | 51114109 |
P2093 | author name string | J M Gaziano | |
L Djoussé | |||
O A Tokede | |||
P2860 | cites work | Meta-analysis in clinical trials | Q27860779 |
Assessing the quality of reports of randomized clinical trials: is blinding necessary? | Q27860973 | ||
Cocoa consumption for 2 wk enhances insulin-mediated vasodilatation without improving blood pressure or insulin resistance in essential hypertension | Q30434226 | ||
Effects of low habitual cocoa intake on blood pressure and bioactive nitric oxide: a randomized controlled trial | Q34645704 | ||
Cardiovascular disease risk of dietary stearic acid compared with trans, other saturated, and unsaturated fatty acids: a systematic review | Q35014581 | ||
Regular consumption of a flavanol-rich chocolate can improve oxidant stress in young soccer players | Q36502116 | ||
Comparison of the effects of diets rich in stearic acid versus myristic acid and lauric acid on platelet fatty acids and excretion of thromboxane A2 and PGI2 metabolites in healthy young men. | Q38565390 | ||
The role of fatty acid saturation on plasma lipids, lipoproteins, and apolipoproteins: I. Effects of whole food diets high in cocoa butter, olive oil, soybean oil, dairy butter, and milk chocolate on the plasma lipids of young men. | Q38565867 | ||
Effects of a milk chocolate bar per day substituted for a high-carbohydrate snack in young men on an NCEP/AHA Step 1 Diet | Q38570677 | ||
Chocolate feeding studies: a novel approach for evaluating the plasma lipid effects of stearic acid | Q38570679 | ||
Short-term effect of cocoa product consumption on lipid profile: a meta-analysis of randomized controlled trials | Q39869352 | ||
The effect of polyphenol-rich dark chocolate on fasting capillary whole blood glucose, total cholesterol, blood pressure and glucocorticoids in healthy overweight and obese subjects | Q43262459 | ||
Flavonoid-rich dark chocolate improves endothelial function and increases plasma epicatechin concentrations in healthy adults. | Q43690454 | ||
Cocoa reduces blood pressure and insulin resistance and improves endothelium-dependent vasodilation in hypertensives. | Q44243592 | ||
Cocoa flavanol-enriched snack bars containing phytosterols effectively lower total and low-density lipoprotein cholesterol levels | Q44322917 | ||
Daily consumption of a dark chocolate containing flavanols and added sterol esters affects cardiovascular risk factors in a normotensive population with elevated cholesterol | Q44325187 | ||
Short-term administration of dark chocolate is followed by a significant increase in insulin sensitivity and a decrease in blood pressure in healthy persons | Q44920445 | ||
A double-blind, placebo-controlled, randomized trial of the effects of dark chocolate and cocoa on variables associated with neuropsychological functioning and cardiovascular health: clinical findings from a sample of healthy, cognitively intact old | Q44937446 | ||
Dark chocolate consumption increases HDL cholesterol concentration and chocolate fatty acids may inhibit lipid peroxidation in healthy humans | Q45083120 | ||
Effect of cocoa flavanols and exercise on cardiometabolic risk factors in overweight and obese subjects. | Q45096941 | ||
Chronic consumption of flavanol-rich cocoa improves endothelial function and decreases vascular cell adhesion molecule in hypercholesterolemic postmenopausal women | Q45290361 | ||
Plasma LDL and HDL cholesterol and oxidized LDL concentrations are altered in normo- and hypercholesterolemic humans after intake of different levels of cocoa powder | Q45352598 | ||
Dark chocolate effect on platelet activity, C-reactive protein and lipid profile: a pilot study | Q46250057 | ||
Sustained benefits in vascular function through flavanol-containing cocoa in medicated diabetic patients a double-masked, randomized, controlled trial | Q46568804 | ||
Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women. | Q50703147 | ||
Effects of cocoa powder and dark chocolate on LDL oxidative susceptibility and prostaglandin concentrations in humans. | Q53677815 | ||
Blood pressure is reduced and insulin sensitivity increased in glucose-intolerant, hypertensive subjects after 15 days of consuming high-polyphenol dark chocolate. | Q55050444 | ||
Comparison of the effects of diets enriched in lauric, palmitic, or oleic acids on serum lipids and lipoproteins in healthy women and men | Q71112134 | ||
Dietary trans fatty acids: effects on plasma lipids and lipoproteins of healthy men and women | Q72338709 | ||
Bioavailability of (-)-epicatechin upon intake of chocolate and cocoa in human volunteers | Q73492276 | ||
Ingested cocoa can prevent high-fat diet-induced obesity by regulating the expression of genes for fatty acid metabolism | Q81684188 | ||
P433 | issue | 8 | |
P921 | main subject | lipid | Q11367 |
meta-analysis | Q815382 | ||
P304 | page(s) | 879-886 | |
P577 | publication date | 2011-05-11 | |
P1433 | published in | European Journal of Clinical Nutrition | Q15756702 |
P1476 | title | Effects of cocoa products/dark chocolate on serum lipids: a meta-analysis | |
P478 | volume | 65 |
Q38666966 | (-)-Epicatechin regulates blood lipids and attenuates hepatic steatosis in rats fed high-fat diet |
Q45758094 | A Systematic Review and Meta-Analysis of the Effects of Flavanol-Containing Tea, Cocoa and Apple Products on Body Composition and Blood Lipids: Exploring the Factors Responsible for Variability in Their Efficacy. |
Q37446962 | A daily glass of red wine and lifestyle changes do not affect arterial blood pressure and heart rate in patients with carotid arteriosclerosis after 4 and 20 weeks |
Q37324802 | A daily glass of red wine associated with lifestyle changes independently improves blood lipids in patients with carotid arteriosclerosis: results from a randomized controlled trial |
Q36117465 | A nutrient-dense, high-fiber, fruit-based supplement bar increases HDL cholesterol, particularly large HDL, lowers homocysteine, and raises glutathione in a 2-wk trial. |
Q36087831 | Acute Cocoa Supplementation Increases Postprandial HDL Cholesterol and Insulin in Obese Adults with Type 2 Diabetes after Consumption of a High-Fat Breakfast |
Q27340167 | Alteration of the systemic and microcirculation by a single oral dose of flavan-3-ols |
Q58730963 | Cardioprotection by Cocoa Polyphenols and ω-3 Fatty Acids: A Disease-Prevention Perspective on Aging-Associated Cardiovascular Risk |
Q34343270 | Cardioprotective effects of cocoa: clinical evidence from randomized clinical intervention trials in humans |
Q34614460 | Changes in body weight, blood pressure and selected metabolic biomarkers with an energy-restricted diet including twice daily sweet snacks and once daily sugar-free beverage |
Q34034430 | Chocolate consumption and prevalence of metabolic syndrome in the NHLBI Family Heart Study |
Q91814469 | Chocolate, "Food of the Gods": History, Science, and Human Health |
Q40306789 | Cocoa Flavanol Supplementation Influences Skin Conditions of Photo-Aged Women: A 24-Week Double-Blind, Randomized, Controlled Trial |
Q38219159 | Cocoa and Human Health: From Head to Foot--A Review |
Q36123571 | Cocoa flavanol intake improves endothelial function and Framingham Risk Score in healthy men and women: a randomised, controlled, double-masked trial: the Flaviola Health Study |
Q36413693 | Consumption of high-polyphenol dark chocolate improves endothelial function in individuals with stage 1 hypertension and excess body weight |
Q37100756 | Consumption of plant seeds and cardiovascular health: epidemiological and clinical trial evidence |
Q92261057 | Dietary Approaches to Stop Hypertension (DASH): potential mechanisms of action against risk factors of the metabolic syndrome |
Q39283890 | Dietary Flavonoid and Lignan Intake and Mortality in Prospective Cohort Studies: Systematic Review and Dose-Response Meta-Analysis |
Q47163649 | Dietary Polyphenols in the Prevention of Stroke |
Q33697812 | Dietary and nutrition interventions for the therapeutic treatment of chronic fatigue syndrome/myalgic encephalomyelitis: a systematic review |
Q39956818 | Dietary cocoa reduces metabolic endotoxemia and adipose tissue inflammation in high-fat fed mice |
Q38211784 | Dietary factors affecting polyphenol bioavailability |
Q41948376 | Effect of Theobromine Consumption on Serum Lipoprotein Profiles in Apparently Healthy Humans with Low HDL-Cholesterol Concentrations. |
Q38514821 | Effect of cocoa products and flavanols on platelet aggregation in humans: a systematic review. |
Q64999086 | Effects of Extra Virgin Olive Oil and Apples Enriched-Dark Chocolate on Endothelial Progenitor Cells in Patients with Cardiovascular Risk Factors: A Randomized Cross-Over Trial. |
Q90079850 | Effects of grape seed extract on dyslipidemia: a systematic review and dose-response meta-analysis of randomized controlled trials |
Q38686874 | Effects of hazelnuts and cocoa on vascular reactivity in healthy subjects: a randomised study. |
Q35400098 | Enhancement of energy expenditure following a single oral dose of flavan-3-ols associated with an increase in catecholamine secretion |
Q24603429 | Evidence for a protective effect of polyphenols-containing foods on cardiovascular health: an update for clinicians |
Q34301108 | Evidence of lifestyle modification in the management of hypercholesterolemia |
Q36838652 | Flavan 3-ols improve metabolic syndrome risk factors: evidence and mechanisms |
Q38925073 | Flavan-3-ol fraction from cocoa powder promotes mitochondrial biogenesis in skeletal muscle in mice |
Q38662167 | Flavonols reduce aortic atherosclerosis lesion area in apolipoprotein E deficient mice: A systematic review and meta-analysis |
Q26744810 | Impact of Cocoa Consumption on Inflammation Processes-A Critical Review of Randomized Controlled Trials |
Q64256375 | Impact of a Usual Serving Size of Flavanol-Rich Cocoa Powder Ingested with a Diabetic-Suitable Meal on Postprandial Cardiometabolic Parameters in Type 2 Diabetics-A Randomized, Placebo-Controlled, Double-Blind Crossover Study |
Q46940639 | Interactions between prebiotics, probiotics, polyunsaturated fatty acids and polyphenols: diet or supplementation for metabolic syndrome prevention? |
Q92252681 | Is there a relationship between chocolate consumption and symptoms of depression? A cross-sectional survey of 13,626 US adults |
Q53502541 | Is there a role for lifestyle changes in cardiovascular prevention? What, when and how? |
Q45305969 | Large-scale randomized clinical trials of bioactives and nutrients in relation to human health and disease prevention - Lessons from the VITAL and COSMOS trials |
Q92808700 | Low Plasma Appearance of (+)-Catechin and (-)-Catechin Compared with Epicatechin after Consumption of Beverages Prepared from Nonalkalized or Alkalized Cocoa-A Randomized, Double-Blind Trial |
Q33816859 | Mechanisms for food polyphenols to ameliorate insulin resistance and endothelial dysfunction: therapeutic implications for diabetes and its cardiovascular complications |
Q92539205 | Metabolite Storage in Theobroma cacao L. Seed: Cyto-Histological and Phytochemical Analyses |
Q38103512 | Modulation of metabolic syndrome-related inflammation by cocoa |
Q49992717 | Optimizing Non-Pharmacologic Management of Hypertriglyceridemia |
Q47190068 | Possible mechanisms of postprandial physiological alterations following flavan 3-ol ingestion |
Q91975986 | Prebiotic Effect of Lycopene and Dark Chocolate on Gut Microbiome with Systemic Changes in Liver Metabolism, Skeletal Muscles and Skin in Moderately Obese Persons |
Q45346482 | Regular consumption of a cocoa product improves the cardiometabolic profile in healthy and moderately hypercholesterolaemic adults |
Q46786956 | Role of Dietary Antioxidants in the Preservation of Vascular Function and the Modulation of Health and Disease |
Q53679696 | Soya products and serum lipids: a meta-analysis of randomised controlled trials. |
Q37318410 | Tea and flavonoids: where we are, where to go next |
Q42182121 | The Cardiovascular Effects of Cocoa Polyphenols-An Overview |
Q38882270 | The Impact of Cocoa Flavanols on Cardiovascular Health |
Q92984097 | The role of bioactives in energy metabolism and metabolic syndrome |
Q88805049 | Theobromine Does Not Affect Fasting and Postprandial HDL Cholesterol Efflux Capacity, While It Decreases Fasting miR-92a Levels in Humans |
Q50057871 | Theobromine consumption does not improve fasting and postprandial vascular function in overweight and obese subjects. |
Search more.